Neurocysticercosis

Archives of Pathology and Laboratory Medicine

Volumn 134, Issue 10, 2010, Pages 1560-1563

  Moskowitz, Jack ^a,b   Mendelsohn, Geoffrey ^a  

^a Western Reserve Care System   (United States)

^b NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER STAGING; DIFFERENTIAL DIAGNOSIS; HUMAN; NEUROCYSTICERCOSIS; PATHOLOGY; PROGNOSIS; REVIEW; UNITED STATES;

DIAGNOSIS, DIFFERENTIAL; HUMANS; NEOPLASM STAGING; NEUROCYSTICERCOSIS; PROGNOSIS; UNITED STATES;

EID: 77958521833     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. DeGiorgio CM, Medina MT, Durón R, Zee C, Escueta SP. Neurocysticercosis. Epilepsy Curr. 2004;4(3):107-111.
2. Scharf D. Neurocysticercosis: two hundred thirty-eight cases from a California hospital. Arch Neurol. 1988;45(7):777-780.
3. García HH, Gonzalez AE, Evans CA, Gilman RH; Cysticercosis Working Group in Peru. Taenia solium cysticercosis. Lancet. 2003;362:547-556.
4. Esberg G, Reske-Nielsen E. Sudden death from cerebral cysticercosis. Scand J Infect Dis. 1988;20(6):679-684.
5. Sorvillo FJ, DeGiorgio C, Waterman SH. Deaths from cysticercosis, United States. Emerg Infect Dis. 2007;13(2):230-235.
6. Earnest MP, Reller LB, Filley CM, Grek AJ. Neurocysticercosis in the United States: 35 cases and a review. Rev Infect Dis. 1987;9(5):961-979.
7. del la Garza Y, Graviss EA, Daver NG, et al. Epidemiology of neurocysticercosis in Houston, Texas. Am J Trop Med Hyg. 2005;73(4):766-770.
8. Wallin MT, Kurtzke JF. Neurocysticercosis in the United States: review of an important emerging infection. Neurology. 2004;63(9):1559-1564.
9. Keane JR. Death from cysticercosis: seven patients with unrecognized obstructive hydrocephalus. West J Med. 1984;140(5):787-789.
10. Garcia HH, Del Brutto OH; Cysticercosis Working Group in Peru. Neurocysticercosis: updated concepts about an old disease. Lancet Neurol. 2005; 4(10):653-661.
11. White AC Jr. Neurocysticercosis: updates on epidemiology, pathogenesis, diagnosis, and management. Annu Rev Med. 2000;51:187-206.
12. Carpio A. Neurocysticercosis: an update. Lancet Infect Dis. 2002;2(12): 751-762.
13. Sorvillo FJ, Portigal L, DeGiorgio C, et al. Cysticercosis-related deaths, California. Emerg Infect Dis. 2004;10(3):465-469.
14. del Brutto OH, Rajshekhar V, White AC Jr, et al. Proposed diagnostic criteria for neurocysticercosis. Neurology. 2001;57(2):177-183.
15. Walker P, Cooper NK, Brandis A. Cerebral sparganosis presenting as grand mal epilepsy. J R Army Med Corps. 2007;153(3):189-190
16. Harrington AT, Creutzfeldt CJ, Sengupta DJ, Hoogestraat DR, Zunt JR, Cookson BT. Diagnosis of neurocysticercosis by detection of Taenia solium DNA using a global DNA screening platform. Clin Infect Dis. 2009;48(1): 86-90.
17. Pittella JE. Neurocysticercosis. Brain Pathol. 1997;7(1):681-693.
18. Escobar A, Weidenheim KM. The pathology of neurocysticercosis. In: Singh G, Prabhakar S, eds. Taenia solium Cysticercosis: From Basic to Clinical Science. Wallingford, United Kingdom: CABI Publishing. 2002:289-305.